[Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
Martín Fontelos
P
P
Servicio de Pediatría, Instituto de Salud Carlos III, Madrid.
Barreiro Casal
G
G
Villota Arrieta
J
J
Pérez Jurado
M L
ML
García López
M
M
Mellado Peña
M J
MJ
Cilleruelo Ortega
M J
MJ
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002439:Cefotaxime / Q000037:antagonists & inhibitors*; D002511:Cephalosporins / Q000037:antagonists & inhibitors*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D008586:Meningitis, Pneumococcal / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012293:Rifampin / Q000008:administration & dosage; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D014640:Vancomycin / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D014640:Vancomycin; D002439:Cefotaxime; D012293:Rifampin